BELKYRA received a positive opinion by the Swedish Medical Products Agency. Read More »

FDA also grants Orphan Drug Designation for the therapy. Read More »

PDL BioPharma recently announced that its has agreed to a $75 million initial equity investment in Noden Pharma DAC, a privately held company based in Ireland, and an affiliate. Read More »

Opens mobile pharmacy to provide pharmacy services to Elkview residents. Read More »

Cigna and Hill Physicians Medical Group have announced that the two companies have agreed to enter a care program partnership that will put an emphasis on the improvement of patient health while decreasing the cost. Read More »

SPIRE-HR and SPIRE-FH lipid-lowering studies meet primary endpoints. Read More »

Copay increases could affect TRICARE beneficiaries' access to prescriptions. Read More »

Store scheduled to open in the mixed use complex in December. Read More »

Ampio Pharmaceuticals Inc. recently announced the results from its PIVOT clinical trials to access the efficacy and safety of Ampion intra-articular injection among patients who have pain from osteoarthritis (OA) in their knees. Read More »

The agreements allow AstraZeneca to focus on its main therapy areas. Read More »

Patent submitted to the FDA Orange Book for approval on June 28. Read More »

Two software programs to integrate and automate medical reviews and payment authorizations. Read More »

Twenty-year FDA veteran tapped to lead OCE through initial phase. Read More »

Company to focus on core assets Mino-Lok and Hydro-Lido. Read More »

Calls on Congress to ban direct-to-consumer advertising; approves policies to help prevent controlled substance abuse. Read More »

Approval includes intravenous use in hospitalized patients with gram-negative bacterial infections. Read More »

Companies working together in a Phase III study of an oral treatment for shingles outbreaks. Read More »

Aratana Therapeutics, Inc., a pet therapeutics company that is dedicated to developing, licensing, and selling innovative biopharmaceutical products specifically for companion animals, recently sent an administration New Animal Drug Application (NADA) to the U.S. Food and Drug Administration (FDA) for its new NOCITA. Read More »

Crown Bioscience (CrownBio), Crown Bioscience International’s wholly owned subsidiary and a worldwide development services company, recently launched its own six new recombinant cell lines dedicated to drug screening, biological studies, development, and discovery. Read More »

Array BioPharma recently announced that it has sent the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for its binimetinib treatment for patients who have advanced NRAS-mutant melanoma. Read More »